Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 268

1.

Clinical features of critically ill patients with Shiga toxin-induced hemolytic uremic syndrome.

Braune SA, Wichmann D, von Heinz MC, Nierhaus A, Becker H, Meyer TN, Meyer GP, Müller-Schulz M, Fricke J, de Weerth A, Hoepker WW, Fiehler J, Magnus T, Gerloff C, Panzer U, Stahl RA, Wegscheider K, Kluge S.

Crit Care Med. 2013 Jul;41(7):1702-10. doi: 10.1097/CCM.0b013e31828a24a8.

PMID:
23660733
2.

Epidemic profile of Shiga-toxin-producing Escherichia coli O104:H4 outbreak in Germany.

Frank C, Werber D, Cramer JP, Askar M, Faber M, an der Heiden M, Bernard H, Fruth A, Prager R, Spode A, Wadl M, Zoufaly A, Jordan S, Kemper MJ, Follin P, Müller L, King LA, Rosner B, Buchholz U, Stark K, Krause G; HUS Investigation Team.

N Engl J Med. 2011 Nov 10;365(19):1771-80. doi: 10.1056/NEJMoa1106483. Epub 2011 Jun 22.

3.

The neurological syndrome in adults during the 2011 northern German E. coli serotype O104:H4 outbreak.

Magnus T, Röther J, Simova O, Meier-Cillien M, Repenthin J, Möller F, Gbadamosi J, Panzer U, Wengenroth M, Hagel C, Kluge S, Stahl RK, Wegscheider K, Urban P, Eckert B, Glatzel M, Fiehler J, Gerloff C.

Brain. 2012 Jun;135(Pt 6):1850-9. doi: 10.1093/brain/aws090. Epub 2012 Apr 26.

4.

Best supportive care and therapeutic plasma exchange with or without eculizumab in Shiga-toxin-producing E. coli O104:H4 induced haemolytic-uraemic syndrome: an analysis of the German STEC-HUS registry.

Kielstein JT, Beutel G, Fleig S, Steinhoff J, Meyer TN, Hafer C, Kuhlmann U, Bramstedt J, Panzer U, Vischedyk M, Busch V, Ries W, Mitzner S, Mees S, Stracke S, Nürnberger J, Gerke P, Wiesner M, Sucke B, Abu-Tair M, Kribben A, Klause N, Schindler R, Merkel F, Schnatter S, Dorresteijn EM, Samuelsson O, Brunkhorst R; Collaborators of the DGfN STEC-HUS registry.

Nephrol Dial Transplant. 2012 Oct;27(10):3807-15. doi: 10.1093/ndt/gfs394.

5.

An outbreak of Shiga toxin-producing Escherichia coli O104:H4 hemolytic uremic syndrome in Germany: presentation and short-term outcome in children.

Loos S, Ahlenstiel T, Kranz B, Staude H, Pape L, Härtel C, Vester U, Buchtala L, Benz K, Hoppe B, Beringer O, Krause M, Müller D, Pohl M, Lemke J, Hillebrand G, Kreuzer M, König J, Wigger M, Konrad M, Haffner D, Oh J, Kemper MJ.

Clin Infect Dis. 2012 Sep;55(6):753-9. doi: 10.1093/cid/cis531. Epub 2012 Jun 5.

6.

Circulating microRNAs in patients with Shiga-Toxin-producing E. coli O104:H4 induced hemolytic uremic syndrome.

Lorenzen JM, Menne J, Schmidt BM, Schmidt M, Martino F, Dietrich R, Samiri S, Worthmann H, Heeren M, Weissenborn K, Haller H, Schiffer M, Kielstein JT, Thum T.

PLoS One. 2012;7(10):e47215. doi: 10.1371/journal.pone.0047215. Epub 2012 Oct 11.

7.

Treatment of severe neurological deficits with IgG depletion through immunoadsorption in patients with Escherichia coli O104:H4-associated haemolytic uraemic syndrome: a prospective trial.

Greinacher A, Friesecke S, Abel P, Dressel A, Stracke S, Fiene M, Ernst F, Selleng K, Weissenborn K, Schmidt BM, Schiffer M, Felix SB, Lerch MM, Kielstein JT, Mayerle J.

Lancet. 2011 Sep 24;378(9797):1166-73. doi: 10.1016/S0140-6736(11)61253-1. Epub 2011 Sep 2.

PMID:
21890192
8.

Duration of fecal shedding of Shiga toxin-producing Escherichia coli O104:H4 in patients infected during the 2011 outbreak in Germany: a multicenter study.

Vonberg RP, Höhle M, Aepfelbacher M, Bange FC, Belmar Campos C, Claussen K, Christner M, Cramer JP, Haller H, Hornef M, Fickenscher H, Fraedrich K, Knobloch JK, Kühbacher T, Manns MP, Nitschke M, Peters G, Pulz M, Rohde H, Roseland RT, Sayk F, Schaumburg F, Schöcklmann HO, Schubert S, Solbach W, Karch H, Suerbaum S.

Clin Infect Dis. 2013 Apr;56(8):1132-40. doi: 10.1093/cid/cis1218. Epub 2013 Jan 8.

9.

Hemolytic-Uremic Syndrome and Escherichia coli O121 at a Lake in Connecticut, 1999.

McCarthy TA, Barrett NL, Hadler JL, Salsbury B, Howard RT, Dingman DW, Brinkman CD, Bibb WF, Cartter ML.

Pediatrics. 2001 Oct;108(4):E59.

PMID:
11581467
10.

Associations of age and sex with the clinical outcome and incubation period of Shiga toxin-producing Escherichia coli O104:H4 infections, 2011.

Werber D, King LA, Müller L, Follin P, Buchholz U, Bernard H, Rosner B, Ethelberg S, de Valk H, Höhle M.

Am J Epidemiol. 2013 Sep 15;178(6):984-92. doi: 10.1093/aje/kwt069. Epub 2013 Aug 8.

11.

Origins of the E. coli strain causing an outbreak of hemolytic-uremic syndrome in Germany.

Rasko DA, Webster DR, Sahl JW, Bashir A, Boisen N, Scheutz F, Paxinos EE, Sebra R, Chin CS, Iliopoulos D, Klammer A, Peluso P, Lee L, Kislyuk AO, Bullard J, Kasarskis A, Wang S, Eid J, Rank D, Redman JC, Steyert SR, Frimodt-Møller J, Struve C, Petersen AM, Krogfelt KA, Nataro JP, Schadt EE, Waldor MK.

N Engl J Med. 2011 Aug 25;365(8):709-17. doi: 10.1056/NEJMoa1106920. Epub 2011 Jul 27.

12.

Postdiarrheal Shiga toxin-mediated hemolytic uremic syndrome similar to septic shock.

Valles PG, Pesle S, Piovano L, Davila E, Peralta M, Principi I, Lo Giudice P.

Medicina (B Aires). 2005;65(5):395-401.

PMID:
16296634
13.

Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion.

Ake JA, Jelacic S, Ciol MA, Watkins SL, Murray KF, Christie DL, Klein EJ, Tarr PI.

Pediatrics. 2005 Jun;115(6):e673-80.

PMID:
15930195
14.

Eculizumab in Typical Hemolytic Uremic Syndrome (HUS) With Neurological Involvement.

Pape L, Hartmann H, Bange FC, Suerbaum S, Bueltmann E, Ahlenstiel-Grunow T.

Medicine (Baltimore). 2015 Jun;94(24):e1000. doi: 10.1097/MD.0000000000001000.

15.

Treatment and outcome of Shiga-toxin-associated hemolytic uremic syndrome (HUS).

Scheiring J, Andreoli SP, Zimmerhackl LB.

Pediatr Nephrol. 2008 Oct;23(10):1749-60. doi: 10.1007/s00467-008-0935-6. Epub 2008 Aug 13. Review.

PMID:
18704506
16.

Association between azithromycin therapy and duration of bacterial shedding among patients with Shiga toxin-producing enteroaggregative Escherichia coli O104:H4.

Nitschke M, Sayk F, Härtel C, Roseland RT, Hauswaldt S, Steinhoff J, Fellermann K, Derad I, Wellhöner P, Büning J, Tiemer B, Katalinic A, Rupp J, Lehnert H, Solbach W, Knobloch JK.

JAMA. 2012 Mar 14;307(10):1046-52. doi: 10.1001/jama.2012.264.

PMID:
22416100
17.

Outbreak of Escherichia coli O104:H4 haemolytic uraemic syndrome in France: outcome with eculizumab.

Delmas Y, Vendrely B, Clouzeau B, Bachir H, Bui HN, Lacraz A, Hélou S, Bordes C, Reffet A, Llanas B, Skopinski S, Rolland P, Gruson D, Combe C.

Nephrol Dial Transplant. 2014 Mar;29(3):565-72. doi: 10.1093/ndt/gft470. Epub 2013 Nov 28.

18.

Outbreak of Shiga toxin-producing Escherichia coli O104:H4 associated with organic fenugreek sprouts, France, June 2011.

King LA, Nogareda F, Weill FX, Mariani-Kurkdjian P, Loukiadis E, Gault G, Jourdan-DaSilva N, Bingen E, Macé M, Thevenot D, Ong N, Castor C, Noël H, Van Cauteren D, Charron M, Vaillant V, Aldabe B, Goulet V, Delmas G, Couturier E, Le Strat Y, Combe C, Delmas Y, Terrier F, Vendrely B, Rolland P, de Valk H.

Clin Infect Dis. 2012 Jun;54(11):1588-94. doi: 10.1093/cid/cis255. Epub 2012 Mar 28.

19.

[Therapy for children with Shiga toxin-E. coli-associated hemolytic uremic syndrome].

Ito K, Hattori M, Matsumoto N.

Nihon Rinsho. 2002 Jun;60(6):1126-30. Review. Japanese.

PMID:
12078084
20.

Critically ill patients with 2009 influenza A(H1N1) infection in Canada.

Kumar A, Zarychanski R, Pinto R, Cook DJ, Marshall J, Lacroix J, Stelfox T, Bagshaw S, Choong K, Lamontagne F, Turgeon AF, Lapinsky S, Ahern SP, Smith O, Siddiqui F, Jouvet P, Khwaja K, McIntyre L, Menon K, Hutchison J, Hornstein D, Joffe A, Lauzier F, Singh J, Karachi T, Wiebe K, Olafson K, Ramsey C, Sharma S, Dodek P, Meade M, Hall R, Fowler RA; Canadian Critical Care Trials Group H1N1 Collaborative.

JAMA. 2009 Nov 4;302(17):1872-9. doi: 10.1001/jama.2009.1496. Epub 2009 Oct 12.

PMID:
19822627
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk